Harmony Biosciences Holdings Inc. (HRMY) Social Stream
HARMONY BIOSCIENCES HOLDINGS INC (HRMY) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering HRMY.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-28 | 4 | $58 | $54 | $56.5 | $35.19 | 60.56% |
| 2022-02-01 | 5 | $60 | $55 | $57.4 | $35.19 | 63.11% |
| 2022-03-01 | 5 | $58 | $55 | $56.8 | $35.19 | 61.41% |
| 2022-04-10 | 5 | $59 | $55 | $57.2 | $35.19 | 62.55% |
| 2022-05-04 | 6 | $63 | $55 | $58.166 | $35.19 | 65.29% |
| 2022-05-10 | 6 | $63 | $55 | $57.833 | $35.19 | 64.34% |
| 2022-07-14 | 8 | $64 | $55 | $59.125 | $35.19 | 68.02% |
| 2022-08-03 | 8 | $64 | $55 | $59.125 | $35.19 | 68.02% |
| 2022-08-04 | 8 | $69 | $55 | $61.285 | $35.19 | 74.15% |
| 2022-10-13 | 7 | $69 | $55 | $61.285 | $35.19 | 74.15% |
| 2022-10-19 | 7 | $69 | $55 | $61.857 | $35.19 | 75.78% |
| 2022-10-21 | 7 | $69 | $51 | $61.285 | $35.19 | 74.15% |
| 2022-11-03 | 8 | $71 | $51 | $63.5 | $35.19 | 80.45% |
| 2022-11-30 | 8 | $71 | $51 | $64.75 | $35.19 | 84% |
| 2023-01-17 | 8 | $71 | $51 | $65.75 | $35.19 | 86.84% |
| 2023-02-22 | 8 | $71 | $51 | $66.375 | $35.19 | 88.62% |
| 2023-04-17 | 8 | $71 | $43 | $63 | $35.19 | 79.03% |
| 2023-04-27 | 9 | $71 | $35 | $59.888 | $35.19 | 70.18% |
| 2023-05-02 | 9 | $71 | $38 | $60.222 | $35.19 | 71.13% |
| 2023-05-03 | 9 | $75 | $38 | $60.666 | $35.19 | 72.4% |
The Trend in the Analyst Price Target
Over the past 30 months, HRMY's average price target has gone up $8.
HRMY reports an average of 40.96% for its upside potential over the past 42 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-07-14 | 8 | 64 | 55 | 59.125 | 52.97 | 11.62% |
| 2022-08-04 | 8 | 69 | 55 | 61.285 | 52.36 | 17.05% |
| 2023-04-17 | 8 | 71 | 43 | 63.000 | 33.35 | 88.91% |
| 2023-04-27 | 9 | 71 | 35 | 59.888 | 31.30 | 91.34% |
| 2023-05-02 | 9 | 71 | 38 | 60.222 | 33.55 | 79.5% |
HRMY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.67 | 5 | 2 | 2 | 0 | 0 | 9 |
The Trend in the Broker Recommendations
HRMY's average broker recommendation rating worsened by 0.17 over the prior 43 weeks.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for HRMY as an investment opportunity.
- To contextualize these metrics, consider that out of all US stocks, HARMONY BIOSCIENCES HOLDINGS INC's variance in analysts' estimates is lower than -502.9% of them.
- In terms of how HARMONY BIOSCIENCES HOLDINGS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is higher than 1732.57% of that group.
- In terms of how HARMONY BIOSCIENCES HOLDINGS INC fares relative to stocks in the mid market cap category, note that its upside potential (average analyst target price relative to current price) is greater than 1552.45% of that group.
- HARMONY BIOSCIENCES HOLDINGS INC's number of analysts covering the stock is greater than 1046.28% of stocks in the mid market cap category.
Stocks similar to HARMONY BIOSCIENCES HOLDINGS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ME, AVIR, and LMDX.
View All Top Stocks by Price Target
Is HRMY a Buy, Hold or Sell? See the POWR Ratings now!